Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-09 Sale | 2024-12-09 8:53 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 61,151 | $32.07 | $1,961,406 | 593,537 (Direct) | View |
| 2024-12-05 Sale | 2024-12-05 6:01 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,221 | $31.5 | $290,462 | 59,730 (Direct) | View |
| 2024-12-04 Sale | 2024-12-04 4:52 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 14,349 | $30.77 | $441,550 | 68,951 (Direct) | View |
| 2024-11-11 Sale | 2024-11-12 4:48 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 58,996 | $30.08 | $1,774,576 | 212,474 (Direct) | View |
| 2024-11-06 Sale | 2024-11-06 7:47 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 10,471 | $29.53 | $309,169 | 99,238 (Direct) | View |
| 2022-02-23 Sale | 2022-02-24 5:34 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 11,983 | $24.76 | $296,650 | 17,994 (Direct) | View |
| 2022-02-18 Sale | 2022-02-23 4:40 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2,306 | $25.17 | $58,042 | 267,600 (Direct) | View |
| 2021-06-09 Sale | 2021-06-11 4:36 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 882 | $24.6 | $21,697 | 0 (Direct) | View |
| 2021-04-15 Sale | 2021-04-16 4:35 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 28,920 | $19.72 | $570,288 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-12-09 Exercise | 2024-12-09 8:53 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 12,044 | $24.59 | 593,537 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-09 8:53 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 12,411 | $26.82 | 593,537 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-09 8:53 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 12,452 | $20.03 | 593,537 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-09 8:53 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 12,090 | $19.34 | 593,537 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-09 8:53 pm | N/A 2030-02-20 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 48,997 | $0 | 593,537 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-12 4:48 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 43,058 | $20.03 | 212,474 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-12 4:48 pm | N/A 2030-02-20 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 43,058 | $0 | 212,474 (Direct) | View |
| 2024-02-23 Tax Withholding | 2024-02-27 4:03 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,414 | $29.57 | 271,427 (Direct) | View |
| 2024-02-26 Option Award | 2024-02-27 4:03 pm | N/A 2034-02-26 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 138,650 | $0 | 271,427 (Direct) | View |
| 2024-02-23 Exercise | 2024-02-27 4:03 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 7,689 | $0 | 271,427 (Direct) | View |
| 2024-02-22 Tax Withholding | 2024-02-23 4:07 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,452 | $28.91 | 117,713 (Direct) | View |
| 2024-02-22 Exercise | 2024-02-23 4:07 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 12,278 | $0 | 117,713 (Direct) | View |
| 2024-02-18 Tax Withholding | 2024-02-21 5:32 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,951 | $32.18 | 116,401 (Direct) | View |
| 2024-02-20 Tax Withholding | 2024-02-21 5:32 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 4,572 | $30.39 | 116,401 (Direct) | View |
| 2024-02-18 Exercise | 2024-02-21 5:32 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 19,194 | $0 | 116,401 (Direct) | View |
| 2023-11-17 Other | 2024-02-12 9:57 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,929 | $19.34 | 1,064,275 (Direct) | View |
| 2024-02-08 Tax Withholding | 2024-02-12 9:57 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 15,280 | $26.77 | 1,064,275 (Direct) | View |
| 2023-11-17 Other | 2024-02-12 9:57 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 1,808 | $0 | 1,064,275 (Direct) | View |
| 2023-11-17 Other | 2024-02-12 9:57 pm | N/A 2027-06-07 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 1,599 | $58.4 | 1,064,275 (Direct) | View |
| 2023-11-17 Other | 2024-02-12 9:57 pm | N/A 2032-02-18 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2,790 | $24.59 | 1,064,275 (Direct) | View |
| 2024-02-08 Option Award | 2024-02-12 9:57 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 46,658 | $0 | 1,064,275 (Direct) | View |
| 2023-11-17 Other | 2024-02-12 9:57 pm | N/A 2028-02-16 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 1,089 | $65.94 | 1,064,275 (Direct) | View |
| 2023-11-17 Other | 2024-02-12 9:57 pm | N/A 2029-02-21 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2,133 | $31.93 | 1,064,275 (Direct) | View |
| 2023-11-17 Other | 2024-02-12 9:57 pm | N/A 2033-02-23 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2,412 | $26.82 | 1,064,275 (Direct) | View |
| 2023-11-17 Other | 2024-02-12 9:57 pm | N/A 2030-02-20 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,376 | $20.03 | 1,064,275 (Direct) | View |
| 2023-03-02 Disposition | 2023-03-02 4:39 pm | N/A N/A | ALBIREO PHARMA INC. | ALBO | Hopkinson Craig C. Director | 10,495 | $0 | 0 (Direct) | View |
| 2023-02-22 Tax Withholding | 2023-02-24 8:23 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,345 | $27.77 | 231,404 (Direct) | View |
| 2023-02-23 Option Award | 2023-02-24 8:23 pm | N/A 2033-02-23 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 150,769 | $0 | 231,404 (Direct) | View |
| 2023-02-22 Exercise | 2023-02-24 8:23 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 12,038 | $0 | 231,404 (Direct) | View |
| 2023-02-21 Tax Withholding | 2023-02-22 4:56 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,053 | $27.77 | 86,129 (Direct) | View |
| 2023-02-18 Tax Withholding | 2023-02-22 4:56 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 12,962 | $28.07 | 86,129 (Direct) | View |
| 2023-02-20 Option Award | 2023-02-22 4:56 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 22,195 | $0 | 86,129 (Direct) | View |
| 2023-02-18 Exercise | 2023-02-22 4:56 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 25,692 | $0 | 86,129 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 4:10 pm | N/A N/A | ALBIREO PHARMA INC. | ALBO | Hopkinson Craig C. Director | 10,495 | $0 | 10,495 (Direct) | View |
| 2022-02-22 Tax Withholding | 2022-02-23 4:40 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,539 | $25.01 | 267,600 (Direct) | View |
| 2022-02-18 Option Award | 2022-02-23 4:40 pm | N/A 2032-02-18 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 174,443 | $0 | 267,600 (Direct) | View |
| 2022-02-20 Tax Withholding | 2022-02-23 4:40 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 4,988 | $25.08 | 267,600 (Direct) | View |
| 2022-02-20 Exercise | 2022-02-23 4:40 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 29,008 | $0 | 267,600 (Direct) | View |
| 2022-02-16 Tax Withholding | 2022-02-17 4:24 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 1,069 | $26.79 | 11,802 (Direct) | View |
| 2022-02-16 Exercise | 2022-02-17 4:24 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,375 | $0 | 11,802 (Direct) | View |
| 2021-09-14 Option Award | 2021-09-16 4:25 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 15,143 | $0 | 9,496 (Direct) | View |
| 2021-09-14 Tax Withholding | 2021-09-16 4:25 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,647 | $30.6 | 9,496 (Direct) | View |
| 2021-06-07 Tax Withholding | 2021-06-08 6:51 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 368 | $23.5 | 882 (Direct) | View |
| 2021-06-07 Exercise | 2021-06-08 6:51 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 1,250 | $0 | 882 (Direct) | View |
| 2021-02-22 Option Award | 2021-02-24 8:54 pm | N/A 2031-02-22 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 244,635 | $0 | 244,635 (Direct) | View |
| 2021-02-20 Tax Withholding | 2021-02-23 9:25 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 5,086 | $19.58 | 72,957 (Direct) | View |
| 2021-02-20 Exercise | 2021-02-23 9:25 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 16,970 | $0 | 72,957 (Direct) | View |
| 2021-02-16 Tax Withholding | 2021-02-18 7:25 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 1,172 | $19.79 | 20,411 (Direct) | View |
| 2021-02-16 Exercise | 2021-02-18 7:25 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,375 | $0 | 20,411 (Direct) | View |
| 2020-02-21 Exercise(A) | 2021-01-15 4:37 pm | 2020-02-21 N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 6,875 | $0 | 36,580 (Direct) | View |
| 2020-06-07 Tax Withholding | 2020-06-08 4:21 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 368 | $17.19 | 16,083 (Direct) | View |
| 2020-06-07 Exercise | 2020-06-08 4:21 pm | 2018-06-07 N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 1,250 | $0 | 16,083 (Direct) | View |
| 2020-02-20 Option Award | 2020-02-24 4:13 pm | 2021-02-20 2030-02-20 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 209,238 | $0 | 323,014 (Direct) | View |
| 2020-02-21 Exercise | 2020-02-24 4:13 pm | 2020-02-21 2029-02-21 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 6,875 | $0 | 323,014 (Direct) | View |
| 2020-02-21 Tax Withholding | 2020-02-24 4:13 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 2,004 | $20.24 | 323,014 (Direct) | View |
| 2020-02-16 Tax Withholding | 2020-02-18 4:10 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 1,172 | $17.77 | 15,830 (Direct) | View |
| 2020-02-16 Exercise | 2020-02-18 4:10 pm | 2019-02-16 N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,375 | $0 | 15,830 (Direct) | View |